Cargando…

Botulinum toxin A improves neurogenic bladder fibrosis by suppressing transforming growth factor β1 expression in rats

BACKGROUND: Intradetrusor botulinum toxin A injection is recommended for the treatment of refractory detrusor overactivity (DO) in patients with neurogenic bladder, however, whether it could inhibit neurogenic bladder fibrosis is uncertain. This study aimed to investigate the effect of botulinum tox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Chunsong, Xing, Tianying, Shang, Zhenhua, Cui, Xin, Wang, Qi, Ou, Tongwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185670/ https://www.ncbi.nlm.nih.gov/pubmed/34159080 http://dx.doi.org/10.21037/tau-21-62

Ejemplares similares

Expression profiles of circular RNAs and interaction networks of competing endogenous RNAs in neurogenic bladder of rats following suprasacral spinal cord injury
por: Ruan, Jimeng, et al.
Publicado: (2023)

MicroRNA expression profile in the spinal cord injured rat neurogenic bladder by next-generation sequencing
por: Shang, Zhenhua, et al.
Publicado: (2020)

Evaluation of neurogenic bladder outlet obstruction mimicking sphincter bradykinesia in male patients with Parkinson’s disease
por: Xing, Tianying, et al.
Publicado: (2021)

Expression profiles of long non-coding RNAs in neurogenic bladder of spinal cord injured rats: a transcriptomic analysis
por: Ruan, Jimeng, et al.
Publicado: (2022)

The role of botulinum toxin A in treating neurogenic bladder
por: Weckx, Filip, et al.
Publicado: (2016)

Botulinum Toxin-A Therapy in Pediatric Urology: Indications for the Neurogenic and Non-Neurogenic Neurogenic Bladder
por: Dyer, Lori, et al.
Publicado: (2009)

Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review
por: Wu, Shu-Yu, et al.
Publicado: (2021)

Pharmacotherapy in Pediatric Neurogenic Bladder Intravesical Botulinum Toxin Type A
por: Sager, Cristian, et al.
Publicado: (2012)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis
por: Bi, Huifeng, et al.
Publicado: (2020)

Predictive Values of Preoperative Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Long-Term Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Patients: A Single-Centre Retrospective Study
por: Bi, Huifeng, et al.
Publicado: (2020)

Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients
por: Shang, Zhenhua, et al.
Publicado: (2018)

Comparison of different antibiotic protocols for asymptomatic bacteriuria in patients with neurogenic bladder treated with botulinum toxin A
por: Paradella, Ana Claudia, et al.
Publicado: (2016)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
por: Wu, Shang-Jun, et al.
Publicado: (2019)

Botulinum toxin in spinal cord injury patients with neurogenic detrusor overactivity
por: Cho, Young Sam, et al.
Publicado: (2016)

Botulinum toxin A for the Treatment of Overactive Bladder
por: Hsieh, Po-Fan, et al.
Publicado: (2016)

The level of zinc finger of the cerebellum 2 is predictive of overall survival in clear cell renal cell carcinoma
por: Shang, Zhenhua, et al.
Publicado: (2020)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
por: Rohrsted, Malene, et al.
Publicado: (2012)

The use of botulinum toxin for the treatment of overactive bladder syndrome
por: Orasanu, Bogdan, et al.
Publicado: (2013)

Telmisartan inhibits bladder smooth muscle fibrosis in neurogenic bladder rats
por: Liu, Qian, et al.
Publicado: (2022)

A pilot prospective study to evaluate whether the bladder morphology in cystography and/or urodynamic may help predict the response to botulinum toxin a injection in neurogenic bladder refractory to anticholinergics
por: Álvares, Ronaldo Alvarenga, et al.
Publicado: (2014)

Editorial Comment: Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2021)

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
por: Averbeck, Marcio Augusto
Publicado: (2022)

Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder
por: Barba, Marta, et al.
Publicado: (2022)

Botulinum toxin: An emerging therapy in female bladder outlet obstruction
por: Pradhan, Aditya A.
Publicado: (2009)

Emerging treatments for overactive bladder: clinical potential of botulinum toxins
por: Tincello, Douglas G, et al.
Publicado: (2014)

Botulinum toxin-A for the treatment of overactive bladder: UK contributions
por: Seth, JH, et al.
Publicado: (2013)

Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis
por: Chiu, Bin, et al.
Publicado: (2016)

The Resonance and the Allium ureteral stents in the treatment of non-malignant refractory ureterostenosis
por: Gao, Wei, et al.
Publicado: (2021)

Neurogenic Bladder
por: Dorsher, Peter T., et al.
Publicado: (2012)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Botulinum Toxin Suppression of CNS Network Activity In Vitro
por: Pancrazio, Joseph J., et al.
Publicado: (2014)

Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorders
por: Alfonsi, Enrico, et al.
Publicado: (2017)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
por: Lombardi, Giuseppe, et al.
Publicado: (2017)

Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
por: Hung, Fan-Ching, et al.
Publicado: (2022)

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder
por: Wada, Naoki, et al.
Publicado: (2022)

Management of neurogenic bladder
por: Oh, Seung-June
Publicado: (2015)

Neuromodulation in neurogenic bladder
por: Sanford, Melissa T., et al.
Publicado: (2016)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_rdo9li5e2p9s1h6c1dugkssrk0